Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA/ FR0013154002 /
DIM
|
2024-04-18 3:31:18 PM
|
Chg.
-43.10
|
Volume |
Bid3:31:20 PM |
Ask3:31:18 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
205.50EUR
|
-17.34%
|
151,883
Turnover: 31.96 mill. |
205.20Bid Size: 5 |
205.80Ask Size: 51 |
19.13 bill.EUR |
0.33% |
61.76 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
3.36 EUR |
-64.67% |
| EPS Diluted: |
- EUR |
-64.67% |
| Revenues per Share: |
30.11 EUR |
-20.53% |
| Book Value per Share: |
28.62 EUR |
7.70% |
| Cash Flow per Share: |
8.10 EUR |
21.90% |
| Dividend per Share: |
0.69 EUR |
-52.08% |
| Total |
in mill. |
|
| Revenues: |
2,775.50 EUR |
-20.53% |
| Net Income: |
309.70 EUR |
-64.65% |
| Operating Cash Flow: |
746.40 EUR |
- |
| Cash and Cash Equivalents: |
116.60 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
61.76 |
71.28 |
| P/S Ratio: |
6.89 |
7.95 |
| P/BV ratio: |
7.25 |
8.37 |
| P/CF Ratio: |
25.63 |
29.58 |
| PEG: |
-0.96 |
-1.10 |
| Earnings Yield: |
1.62% |
1.40% |
| Dividend Yield: |
0.33% |
0.29% |
| Market Capitalization |
|
| Market Capitalization: |
19.13 bill. EUR |
22.08 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
1.79 mill. EUR |
2.07 mill. EUR |
| Shares Outstanding: |
92.18 mill. |
|
Profitability
| Gross Profit Margin: |
44.44% |
| EBIT Margin: |
16.17% |
| Net Profit Margin: |
11.16% |
| Return on Equity: |
11.74% |
| Return on Assets: |
4.00% |
Financial Strength
| Liquidity I / Cash Ratio: |
12.44% |
| Liquidity II / Quick Ratio: |
43.77% |
| Liquidity III / Current Ratio: |
150.98% |
| Debt / Equity Ratio: |
193.41% |
| Dynam. Debt / Equity Ratio: |
683.55% |
Efficiency
| Employees: |
10,662 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
260,317.01 EUR |
| Net Income / Employee: |
29,047.08 EUR |
| Total Assets / Employee: |
725,933.22 EUR |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
